FANCC-C9ORF3 Fusion FISH Probe
The FANCC-C9ORF3 Fusion FISH Probe is used to confirm a fusion of the FANCC and C9ORF3 genes. The fusion of the FANCC and C9ORF3 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FANCC-C9ORF3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FANCC-C9ORF3-20-AQAQ | 20 (40 μL) | 200 μL |
|
FANCC Gene Summary
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
Gene Name: Fanconi Anemia Complementation Group C
Chromosome: CHR9: 97861335 -98079991
Locus: 9q22.32
C9orf3 Gene Summary
This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]
Gene Name: Chromosome 9 Open Reading Frame 3
Chromosome: CHR9: 97488950 -97849500
Locus: 9q22.32
Gene Diseases
The FANCC C9ORF3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|